DOCSLIB.ORG

Product List - Complete Probemix List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Product List - Complete Probemix List gen-diagnostics - product list - complete probemix list Product Name Application Region A054-Campylobacter MBiT mix 1 basic Genotyping of Campylobacter jejuni isolates Campylobacter research A055-Campylobacter MBiT mix 2 basic Genotyping of Campylobacter jejuni isolates Campylobacter research ME001-Tumour suppressor mix 1 basic Tumour suppressor genes Various research ME002-Tumour suppressor mix 2 basic Tumour suppressor genes Various research ME011-MMR Mismatch repair genes (MMR) MLH1, MSH2, MSH6, MLH3, MSH3, PMS2, MGMT ME012-MGMT-IDH1-IDH2 Gliomas MGMT, IDH1, IDH2 ME024-9p21 Tumours, Cutaneous melanoma 9p21, CDKN2A, CDKNA2B ME028-PWS/AS Prader Willi syndrome (PWS), Angelman syndrome (AS) PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 ME029-FMR1/AFF2 Fragile X FMR1, AFF2 ME030-BWS/RSS Beckwith-Wiedemann Syndrome (BWS), Russell-Silver 11p15 region, H19, IGF2, CDKN1C, Syndrome (RSS) KCNQ1 ME031-GNAS Albright hereditary osteodystrophy (AHO), GNAS 20q13.32 Pseudohypoparathyroidism (PHP) ME032-UPD7-UPD14 Uniparental disomy 6q24, 7p12, 7q32 and 14q32 ME033-TNDM Transient neonatal diabetes mellitus 6q24 ME042-CIMP basic research CpG Island Methylator Phenotype Various P002-BRCA1 CE Hereditary breast cancer (BRCA1) BRCA1 17q21.31 P003-MLH1/MSH2 CE Lynch Syndrome MLH1 3p22.2, MSH2 2p21 P004-ERBB2 Cancer ERBB2 (HER2-NEU) 17q21.1 P008-PMS2 Lynch Syndrome PMS2 7p22 P010-POLG Mitochondrial maintenance POLG, POLG2, TWNK (C10orf2; PEO1), SLC25A4 (ANT1) P011-VWF mix 1 Von Willebrand Disease (vWD) vWF 12p13 P012-VWF mix 2 Von Willebrand Disease (vWD) vWF 12p13 P013-ATRX Alpha-Thalassemia/Mental Retardation ATRX ; Xq13 P014-Chromosome 8 Tumour research Chromosome 8 P015-MECP2 RETT syndrome MECP2, Xq28 P016-VHL CE Von Hippel-Lindau Syndrome VHL, 3p25 P017-MEN1 Multiple endocrine neoplasia MEN1 11q13 P018-SHOX CE Idiopathic growth retardation SHOX-Xp22 P021-SMA Spinal Muscular Atrophy (SMA) SMN1, SMN2, 5q13 P022 -PLP1 Pelizaeus-Merzbacher disease (PMD) PLP1 Xq22 P025-Canavan Canavan disease ASPA, 17p13 P026-Sotos improved Sotos syndrome NSD1, 5q35 2017-05-10 11:17 copyright © 2017 MRC-Holland page 1 of 12 gen-diagnostics - product list - complete probemix list P027-Uveal melanoma Uveal melanoma 1p, chr.3, 6p, 8q P028-FHL Familial lymphohistiocytosis (HLH) UNC13D 17q25.1, PRF1 10q22.1, STX11 6q24.2 P029-WBS Williams-Beuren syndrome WBS criticial region 7q11.23 P031-FANCA mix 1 Fanconi Anemia (FA) FANCA 16q24.3 P032-FANCA mix 2 Fanconi Anemia (FA) FANCA 16q24.3 P033-CMT1 CE Charcot-Marie Tooth disease (CMT1), Hereditary CMT1/HNPP region, 17p12 Neuropathy with liability to Pressure Palsies (HNPP) P034-DMD-1 CE Duchenne Muscular Dystrophy (DMD) DMD, Xp21.2 P035-DMD-2 CE Duchenne Muscular Dystrophy (DMD) DMD, Xp21.2 P036-Subtelomeres Mix 1 CE Subtelomeric testing All subtelomeres P037-CLL-1 Chronic Lymphocytic Leukemia (CLL) Various P038-CLL-2 Chronic Lymphocytic Leukemia (CLL) Various P040-CLL Chronic Lymphocytic Leukemia (CLL) Various P041-ATM-1 CE Ataxia-Telangiectasia (AT) ATM 11q23 P042-ATM-2 CE Ataxia-Telangiectasia (AT) ATM 11q23 P043-APC improved Hereditary Polyposis Colon Cancer APC, 5q21-q22 P044-NF2 Neurofibromatosis type 2 (NF2) NF2 22q12 P045-BRCA2/CHEK2 CE Breast cancer, hereditary BRCA2, CHEK2 P046-TSC2 Tuberous Sclerosis TSC2 16p13.3 P047-RB1 Retinoblastoma (RB) RB1 13q14 P048-LMNA/MYOT/ZMPSTE24 Laminopathies, Limb-girdle muscular dystrophy, LMNA 1q22; ZMPSTE24 1p34; MYOT Myofibrillar myopathies 5q31; CAV3 3p25 P049-SLC6A8 - ABCD1 Creatine transporter, x-linked SLC6A8, Xq28 P050-CAH Congenital Adrenal Hyperplasia CYP21A2 6p21.3 P051-Parkinson mix 1 Parkinson disease, familial PARK2 6q25.2, SNCA 4q21, Pink1, Park7 1p36 P052-Parkinson mix 2 Parkinson disease, familial PARK2 6q25.2, UCHL1 4p14, GCH1 14q22.1, LRRK2 12q12 P054-FOXL2-TWIST1 Ophthalmogenetic anomalies FOXL2 , TWIST1, FOXC1, FOXC2, ATR, PITX2, GPR143 P055-PAH CE Phenylketonuria PAH 12q23.2 P056-TP53 Li-Fraumeni syndrome (LFS) and tumour analysis TP53 17p13.1 P057-FANCD2-PALB2 Fanconi anemia (FA) FANCD2. 3p25.3, PALB2 16p12 P058-IGHMBP2 Distal spinal muscular atrophy 1 (DSMA1), SMARD1, IGHMBP2 11q13 dHMN6 P059-Dystonia Dystonia PRKRA; THAP1; TOR1A; ATP1A3 P060-SMA CE Spinal Muscular Atrophy (SMA) SMN1, SMN2, 5q13 P061-Lissencephaly improved Lissencephaly LIS1, DCX, POMT1, POMGnT1, FLNA P062-LDLR CE Hypercholesterolemia, familial LDLR 19p13.2 P063-FHIT-WWOX Diverse tumour types, epileptic encephalopathy FHIT (3p14.2) and WWOX (16q23.1) 2017-05-10 11:17 copyright © 2017 MRC-Holland page 2 of 12 gen-diagnostics - product list - complete probemix list P064-MR-1 Mental Retardation; 1p-deletion, Williams, Smith- Various Magenis, Miller-Dieker, DiGeorge, Prader-Willi, Alagille, Saethre-Chotzen, Sotos P065-Marfan-1 Marfan syndrome FBN1 15q21.1, TGFBR2 3p22 P066-Marfan-2 Marfan syndrome FBN1 15q21.1 P067-PTCH1 Gorlin syndrome PTCH1 9q22.3 P069-Subtelomeres Mix 2A CE Subtelomeric testing All subtelomeres P070-Subtelomeres Mix 2B CE Subtelomeric testing All subtelomeres P071-LMNB1-PLP1-NOTCH3 Leukodystrophy LMNB1 5q23.2, PLP1 Xq22.2, NOTCH3 19p13.12 P072-MSH6 Lynch Syndrome MSH6 P073-IKBKG Incontinentia Pigmenti Xq28; IKBKG, NEMO, IKBKGP P074-AR Androgen insensitivity syndrome (AIS) AR Xq12 P075-TCF4-FOXG1 Pitt-Hopkins syndrome, Congential variant of Rett TCF4, FOXG1 syndrome P076-ACADVL-SLC22A5 VLCAD/Primary Carnitine ACADVL, SLC22A5 P077-BRCA2 Breast cancer, hereditary BRCA2 P078-Breast tumour Breast tumour various P079-OTC Ornithine transcarbamylase (OTC) OTC Xp11.4 P080-Craniofacial Craniofacial disorders FGFRs, TWIST, MSX2, ALX4, RUNX2 P081-NF1 mix 1 Neurofibromatosis NF1 17q11.2 P082-NF1 mix 2 Neurofibromatosis NF1 17q11.2 P083-CDH1 Hereditary diffuse gastric cancer CDH1 at 16q22.1 P087-BRCA1 Breast cancer, hereditary BRCA1 P088-Oligodendroglioma 1p-19q Oligodendroglioma 1p, 19q, IDH1/2, CDKN2A/2B P089-TK2 mtDNA depletion syndrome TK2, MPV17, DGUOK, RRM2B, SUCLA2, SUCLG1 P090-BRCA2 CE Breast cancer, hereditary BRCA2 13q13.1 P091-CFTR CE Cystic Fibrosis CFTR 7q31.2 P092-ABCC6 Pseudoxanthoma elasticum ABCC6 16p13.11 P093-HHT/PPH1 Hemorrhagic telangiectasia, hereditary (HHT), Primary ENG 9q34.11, ACVRL1 12q13.3, BMPR2 pulmonary hypertension (PPH1) 2q33.1-2 P094-MEFV Mediterranean fever, familial (MEFV) MEFV 16p13.3 P095-Aneuploidy CE Down syndrome, Edwards syndrome, Patau syndrome Chr. 13, 18, 21, X, Y P096-MR-2 Mental retardation, Wolf-Hirschhorn, Cri du Chat, Langer- Various Giedon, WAGR, Rubinstein-Taybi, Down, Kabuki P098-Wilson Wilson disease ATP7B 13q14.3 P099-GCH1-TH-SGCE Dopa-responsive dystonia, Segawa disease; Myoclonus- TH 11p15.5, GCH114q22, SGCE 7q21 dystonia syndrome P100-MYBPC3 Hypertrophic cardiomyopathy, familial MYBPC3 11p11.2 P101-STK11 Peutz-Jeghers syndrome (PJS) STK11 19p13.3 P102-HBB Thalassemia, beta-zero HBB 11p15.5 2017-05-10 11:17 copyright © 2017 MRC-Holland page 3 of 12 gen-diagnostics - product list - complete probemix list P103-DPYD Dihydropyrimidine dehydrogenase (DPYD) deficiency DPYD 1p22 P104-Menkes ATP7A Menkes disease ATP7A Xq13.3 P105-Glioma-2 Glioma, malignant EGFR, TP53, PTEN + various other P106-MRX Mental retardation, x-linked (XLMR) Chromosome X P107-Neurometabolic Neurometabolic disorders ASPA, MLC1, MLYCD, D2HGDH, L2HGDH P108-SCN5A Brugada / long QT SCN5A 3p22 P109-ABCB4 Drug-transport pump ABCB4 7q21,1 P110-FCGR mix 1 basic research FCGR genes 1q23.3 FCGR genes 1q23.3 P111-FCGR mix 2 basic research FCGR genes 1q23.3 FCGR genes 1q23.3 P112-PROS1 PROS1 deficiency PROS1 3q11.2 P114-Long-QT Congenital long QT syndrome (LQT) KCNQ1 11p15.5, KCNH2 7q35 P116-SGC Limb-girdle muscular dystrophy (LGMD) SGCA, SGCB, SGCD, SGCG, FKRP P117-ABCC8 Hyperinsulinemic hypoglycemia, familial (HHF1) ABCC8 11p15.1 P118-WT1 Wilms tumours, WAGR, Denys-Drash, Frasier syndrome. WT1 11p13 P120-PANK2/PLA2G6 Neurodegeneration with brain iron accumulation (NBIA) PANK2 20q13, PLA2G6 22q13 P122-NF1-area Neurofibromatosis NF1 17q11.2 P124-TSC1 Tuberous Sclerosis TSC1 9q34 P125-Mitochondria Mitochondrial DNA (mtDNA) Mitochondria P128-CYP450 basic research Cytochrome P-450 CYP2D6, CYP2C9, CYP2C19, CYP1B1, CYP3A4, CYP3A5, CYP2E1, CYP1A1, CYP1A2, CYP2A6, CYP2B6, GSTP1, GSTT1 and GSTM1 P129-GJB1 Charcot Marie Tooth disease, x-linked GJB1 Xq13.1 P130-CCM mix-1 Cerebral Cavernous Malformations (CCM) CCM 7q21 P131-CCM mix-2 Cerebral Cavernous Malformations (CCM) CCM 7q21 P133-Kallmann-2 Kallmann syndrome FGFR1 8p11.2, GNRHR 8p21, KISSR1 19p13.3 , GNRH1, NELF 9q34.3 P136-Gitelman Gitelman syndrome SLC12A3 16q13 P137-SCN1A Epilepsy SCN1A 2q24.3 P138-SLC2A1-STXBP1 Glut1 deficiency syndrome SLC2A1, STXBP1 P140-HBA CE Thalassemias, Alpha HBA 16p P141-NIPBL-1 Cornelia de Lange syndrome (CDLS) NIPBL 5p13.2 P142-NIPBL-2 Cornelia de Lange syndrome (CDLS) NIPBL 5q13.1 P143-MFN2-MPZ Charcot-Marie-Tooth disease (CMT2A/1B) MFN2 1p36.22, MPZ 1q23.3 P146-CRC GAIN basic research Colon cancer Various P147-1p36 1p36 deletion syndrome 1p36 P148-TGFBR1-TGFBR2 Aortic aneurysm syndrome TGFBR1 9q22, TGFBR2 3p22 P151-ABCA4 mix-1 Stargardt, Macular dystrophy, Retinitis pigmentosa, age- ABCA4 (ABCR) 1p22.1 related macular degeneration, cone rod dystrophies P152-ABCA4 mix-2 Stargardt, Macular dystrophy, Retinitis pigmentosa, age- ABCA4 (ABCR) 1p22.1 2017-05-10 11:17 copyright © 2017 MRC-Holland page 4 of 12 gen-diagnostics - product list - complete probemix list related macular degeneration, cone rod dystrophies P153-EYA1 Branchio-oto-renal dysplasia syndrome (BOR) EYA1 8q13.3. P154-GPC3-GPC4 Simpson-Golabi-Behmel syndrome (SGBS) GPC3, GPC4, Xq26 P155-EDS The Ehlers-Danlos
Load more

Recommended publications
  • DIAGMOL Town, ZIPCODE :…………………………………………………… Director : Prof
    Mr. Mrs. (IN UPPER CASE, please) Name:……………………………………………………. Maiden Name:……………………………………. DMGL / Service de Médecine Génétique Centre d’accueil des prélèvements (CAP) First name :………………………………………………… Bâtiment des Laboratoires (BATLab), local 8D-0-850.1 Date of birth : ............ / ........... / …………… 4 rue Gabrielle-Perret-Gentil, 1211 Genève 14 Legal representative (for minors) : father mother Molecular and Genomic Diagnostics Laboratory Name/first name :…………………………………………… Street/N°:……………………………………………………… http://www.hug-ge.ch/feuilles-de-demande DIAGMOL Town, ZIPCODE :…………………………………………………… Director : Prof. Stylianos ANTONARAKIS Hospitalisation Unit: …………… Physician :…………………… Lab managers: N° EdS : …………………………………………………………… Dr J.-L. BLOUIN, Dr Th. NOUSPIKEL, Dr. M. GUIPPONI Invoice address: Patient Prescriptor Insurance [email protected], [email protected], [email protected] Type of case : Disease AI Accident Pregnancy Lab direct or results: Phone/FAX: +41 (0) 22 37 21 826 / 21 860 N° AVS (Mandatory for AI) : ………………………...................... Sample Entrance Center (CAP) : Phone +41 (0) 22 37 21 800 Insurance : ………………… Insured N° : ……………………… PHYSICIAN PHYSICIAN (NAME/First name - Street/N°- Town, ZIPCODE - Phone/FAX. IN UPPER CASES, PLEASE) COPY TO OTHER PHYSICIAN (NAME/First name - Street/N°- Town, ZIPCODE - Phone/FAX. IN UPPER CASES, PLEASE) « The laboratory is granted permission by the Physician/Patient to transmit copies of the report to other physicians» Opposition of the patient to the registration of this request results in the electronic patient record (DPI) of the HUG If the patient belongs to a family already known to the laboratory, please indicate index case NAME: CLINICAL INFORMATIONS given by the physician: Ethnic origins Father Mother Currently pregnant Date of last menses Number of weeks of amenorrhea SAMPLE(S) Most of our tests work from 4 ml of blood in EDTA (children <2 ans : 1 On every and single NAME First name ml : ok) or from purified DNA (some exceptions apply for some tests) tube.
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulphonylurea-Sensitive Diabetes
    Diabetes Care 1 Shivani Misra,1 Neelam Hassanali,2 Homozygous Hypomorphic Amanda J. Bennett,2 Agata Juszczak,2 Richard Caswell,3 Kevin Colclough,3 HNF1A Alleles Are a Novel Cause Jonathan Valabhji,4 Sian Ellard,3 of Young-Onset Diabetes and Nicholas S. Oliver,1,4 and Anna L. Gloyn2,5,6 Result in Sulphonylurea-Sensitive Diabetes https://doi.org/10.2337/dc19-1843 OBJECTIVE Heterozygous loss-of-function mutations in HNF1A cause maturity-onset diabetes of the young (MODY). Affected individuals can be treated with low-dose sulpho- nylureas. Individuals with homozygous HNF1A mutations causing MODY have not been reported. RESEARCH DESIGN AND METHODS We phenotyped a kindred with young-onset diabetes and performed molecular genetic testing, a mixed meal tolerance test, a sulphonylurea challenge, and in vitro assays to assess variant protein function. RESULTS A homozygous HNF1A variant (p.A251T) was identified in three insulin-treated 1 family members diagnosed with diabetes before 20 years of age. Those with the Diabetes, Endocrinology and Metabolism, Im- NOVEL COMMUNICATIONS IN DIABETES homozygous variant had low hs-CRP levels (0.2–0.8 mg/L), and those tested dem- perial College London, London, U.K. 2Oxford Centre for Diabetes, Endocrinology and onstrated sensitivity to sulphonylurea given at a low dose, completely transitioning off Metabolism, University of Oxford, Oxford, U.K. insulin. In silico modeling predicted a variant of unknown significance; however, in vitro 3Institute of Biomedical and Clinical Science, Uni- studies supported a modest reduction in transactivation potential (79% of that for the versity of Exeter Medical School, Exeter, U.K.
    [Show full text]
  • UNSCEAR 2001 Report to the General Assembly, with Scientific Annex
    HEREDITARY EFFECTS OF RADIATION United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2001 Report to the General Assembly, with Scientific Annex UNITED NATIONS HEREDITARY EFFECTS OF RADIATION United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 2001 Report to the General Assembly, with Scientific Annex UNITED NATIONS New York, 2001 NOTE The report of the Committee without its scientific annex appears as Official Records of the General Assembly. Fifty-sixth Session, Supplement No. 46 (N56146). The designation employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the pad of the Secretariat of the United Nationsconcerning the legal status of any country, temtory, city orarea, or of its authorities, or concerning the delimitation of its frontiers or boundaries. The country names used in this document are, In most cases, those that were in use at the time the data were collected or the text prepared. In othercases, however, the names have been updated, where this was posslble and appropriate, to reflect political changes. UNITED NATIONS PUBLICATION Sales No. E.O1 .IX.2 ISBN 92-1-1 42244-2 Report of the United Nations Scientific Committee on the Effects of Atomic Radiation to the General Assembly 1. During the past few years, the United Nations 4. The Committee wishes to acknowledge the assistance Scientific Committee on the Effects of Atomic Radiation1 of the consultant, K. Sankaranarayanan, in the preparation has undertaken broad reviews of the sources and effects of of the scientific annex and the advice of the international ionizing radiation.
    [Show full text]
  • Uncommon Forms of Diabetes
    Clinical Medicine 2021 Vol 21, No 4: e337–41 CME: DIABETES Uncommon forms of diabetes Authors: Yun-Ni LeeA and Mohammed SB HudaB Diabetes mellitus is a common condition which all clinicians and insulin independence. It is estimated to account for 1%–2% will encounter in their clinical practice. The most common of patients diagnosed with diabetes and, in the UK, the prevalence form is type 2 diabetes followed by type 1 diabetes. However, of MODY is estimated to be at 108 cases per million.3 However, there are many other atypical forms of diabetes which are it may be a significant underestimate and these figures are not important for a clinician to consider as it can impact on the accurate until large population screening studies are performed. ABSTRACT diagnosis and their management. The most common mutations are hepatocyte nuclear factor-1- This article focuses on maturity onset diabetes of the young alpha (HNF1α; 52%), glucokinase (GCK; 32%) and HNF4α (10%), (MODY), latent autoimmune diabetes in adults (LADA), see Table 2.3 ketosis-prone diabetes and other secondary forms of diabetes such as pancreatic cancer and haemochromatosis. We briefly Hepatocyte nuclear factor-1-alpha gene describe the key clinical features of these forms of diabetes and their investigations and treatment. Formerly called MODY3, mutations on the HNF1α gene on chromosome 3 are associated with a progressive defect of insulin secretion.4 Mutations here also result in low renal threshold for 5 Introduction glucose and thus mutation carriers have detectable glycosuria. In the UK, around 90% of people with diabetes have type 2 diabetes (T2D), around 8% have type 1 diabetes (T1D) and around 2% have other forms of diabetes.1 Key points Typically, we see T1D present in a young, lean patient with Suspect other uncommon forms of diabetes if the clinical marked symptoms of polyuria, polydipsia, weight loss and diabetic picture does not fit type 1 or type 2 diabetes.
    [Show full text]
  • Two MODY 2 Families Identified in Brazilian Subjects
    case report Incidental mild hyperglycemia in children: two MODY 2 families identified in Brazilian subjects Hiperglicemia incidental em crianças: duas famílias com MODY 2 identificadas em brasileiros Lílian A. Caetano1,2, Alexander A. L. Jorge1, Alexsandra C. Malaquias1, Ericka B. Trarbach1, Márcia S. Queiroz2, Márcia Nery2, Milena G. Teles1,2 SUMMARY Maturity-onset diabetes of the young (MODY) is characterized by an autosomal dominant mode 1 Unidade de Endocrinologia of inheritance, early onset of hyperglycemia, and defects of insulin secretion. MODY subtypes Genética e Laboratório de described present genetic, metabolic, and clinical differences. MODY 2 is characterized by mild Endocrinologia Molecular e Celular/LIM25, Disciplina de asymptomatic fasting hyperglycemia, and rarely requires pharmacological treatment. Hence, Endocrinologia, Faculdade precise diagnosis of MODY is important for determining management and prognosis. We report de Medicina da Universidade two heterozygous GCK mutations identified during the investigation of short stature. Case 1: a de São Paulo (FMUSP), São Paulo, SP, Brazil prepubertal 14-year-old boy was evaluated for constitutional delay of growth and puberty. During 2 Unidade de Diabetes, follow-up, he showed abnormal fasting glucose (113 mg/dL), increased level of HbA1c (6.6%), and Hospital das Clínicas, FMUSP, negative β-cell antibodies. His father and two siblings also had slightly elevated blood glucose le- São Paulo, SP, Brazil vels. The mother had normal glycemia. A GCK heterozygous missense mutation, p.Arg191Trp, was identified in the proband. Eighteen family members were screened for this mutation, and 11 had the mutation in heterozygous state. Case 2: a 4-year-old boy investigated for short stature revealed no other laboratorial alterations than elevated glycemia (118 mg/dL); β-cell antibodies were nega- tive.
    [Show full text]
  • Mat Kadi Tora Tutti O Al Ut Hit Hitta Atuh
    MAT KADI TORA TUTTI USO AL20180235194A1 UT HIT HITTA ATUH ( 19) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0235194 A1 Fahrenkrug et al. (43 ) Pub . Date : Aug . 23, 2018 ( 54 ) MULTIPLEX GENE EDITING Publication Classification (51 ) Int. Ci. ( 71 ) Applicant: Recombinetics , Inc ., Saint Paul, MN A01K 67/ 027 (2006 . 01 ) (US ) C12N 15 / 90 ( 2006 .01 ) (72 ) Inventors : Scott C . Fahrenkrug, Minneapolis , (52 ) U . S . CI. MN (US ) ; Daniel F . Carlson , CPC .. .. A01K 67 / 0276 (2013 . 01 ) ; C12N 15 / 907 Woodbury , MN (US ) ( 2013 .01 ) ; A01K 67 /0275 ( 2013 .01 ) ; A01K 2267/ 02 (2013 .01 ) ; AOIK 2217 / 15 (2013 .01 ) ; AOIK 2227 / 108 ( 2013 .01 ) ; AOIK 2217 /07 (21 ) Appl. No. : 15 /923 , 951 ( 2013 .01 ) ; A01K 2227/ 101 (2013 .01 ) ; AOIK ( 22 ) Filed : Mar. 16 , 2018 2217 /075 ( 2013 .01 ) (57 ) ABSTRACT Related U . S . Application Data Materials and methods for making multiplex gene edits in (62 ) Division of application No . 14 /698 ,561 , filed on Apr. cells and are presented . Further methods include animals 28 , 2015, now abandoned . and methods of making the same . Methods of making ( 60 ) Provisional application No . 61/ 985, 327, filed on Apr. chimeric animals are presented , as well as chimeric animals . 28 , 2014 . Specification includes a Sequence Listing . Patent Application Publication Aug . 23 , 2018 Sheet 1 of 13 US 2018 / 0235194 A1 GENERATION OF HOMOZYGOUS CATTLE EDITED AT ONE ALLELE USING SINGLE EDITS Edit allele , Raise FO to Mate FO enough times Raise F1s to Mate F1 siblings Clone cell , sexual maturity , to produce enough F1 sexualmaturity , to make Implant, Gestate 2 years generation carrying 2 years homozygous KO , 9 months , birth edited allele to mate 9 months of FO with each other Generation Primary Fibroblasts ? ? ? Time, years FIG .
    [Show full text]
  • Endocrine Genetic Test List
    Endocrine Genetic Test List Associated conditions Test No. Test Name Genes Included and phenotypes Bone HPP, X-Linked Hypophosphatemia, X-Linked Hypophosphatemic Rickets, XLH, Hypophosphatemic Rickets, X-Linked Hypophosphatasia and Dominant Hypophosphatemic Rickets (XLHR), ALPL, CLCN5, CYP2R1, CYP27B1, DMP1, ENPP1, FGF23, PHEX, 630292 Hypophosphatemic Rickets X-Linked Rickets (XLR), Vitamin D-Resistant SLC34A3, VDR Panel Rickets, X-Linked Vitamin D-Resistant Rickets (VDRR), Hypophosphatemic Vitamin D-Resistant Rickets (HPDR), Phosphate Diabetes, Familial Hypophosphatemic Rickets BMP1, COL1A1, COL1A2, CREB3L1, CRTAP, FKBP10, IFITM5, LRP5, Osteogenesis Imperfecta 630543 MBTPS2, P3H1, PLOD2, PPIB, SERPINF1, SERPINH1, SP7, SPARC, OI, Juvenile Primary Osteoporosis Genetic Panel TENT5A, TMEM38B, WNT1 Cancer Familial Isolated Hyperparathyroidism, VistaSeq® Endocrine Cancer CDC73, MAX, MEN1, NF1, PRKAR1A, PTEN, RET, SDHB, SDHC, SDHD, 481374 Multiple Endocrine Neoplasia, Paraganglioma, Panel* TMEM127, TP53 and VHL Parathyroid Cancer, Pheochromocytoma Diabetes and Insulin Maturity-Onset Diabetes of the 630568 GCK, HNF1A, HNF1B, HNF4A Young (MODY) 4-gene Panel Maturity-Onset Diabetes of ABCC8, APPL1, BLK, GCK, HNF1A, HNF1B, HNF4A, INS, KCNJ11, 630513 the Young (MODY) Expanded KLF11, NEUROD1, PAX4, PDX1 Genetic Panel Congenital Hyperinsulinism ABCC8, GCK, GLUD1, HADH, HNF1A, HNF4A, KCNJ11, PGM1, PMM2, 630500 Hypoglycemia Genetic Panel SLC16A1, UCP2 Growth and Development Combined Pituitary Hormone GLI1, HESX1, LHX3, LHX4, OTX2, POU1F1, PROKR2, PROP1,
    [Show full text]
  • An Interesting Case of Young Onset Diabetes Mellitus
    International Journal of Research in Medical Sciences Gulati S et al. Int J Res Med Sci. 2017 Sep;5(9):4178-4180 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20174007 Case Report An interesting case of young onset diabetes mellitus Shipra Gulati*, Tanvi Batra, Akshay A. Dhamne, Vijayashree S. Gokhale Department of Medicine, Dr. DY Patil Medical College and Hospital, Pimpri, Pune, Maharashtra, India Received: 23 June 2017 Accepted: 22 July 2017 *Correspondence: Dr. Shipra Gulati, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT A 24 years old female, was admitted with symptoms of urinary tract infection. She was married and had bad obstetric history. She was known diabetic for 16 years of age and was on regular treatment with injection human insulin mixtard since the time of diagnosis, but had no episode of diabetic ketosis/ ketoacidosis. She had a positive family history of diabetes. She was further evaluated and was found to have normal C peptide levels and islet cell antibodies were found to be negative. Hence, the possibility of MODY (monogenic diabetes) was considered. Her genetic testing could not be done due to financial constraints. But a trial of sulfonylureas was given along with reduction in the dose of insulin to which she responded well and is presently well controlled.
    [Show full text]
  • Servicios GENYCA 20171218 ENGLISH
    RARE DISEASES GENYCA_2018 TAT* CODE TEST OMIM ANALYSIS OF: GENES SAMPLE SPECIALITY (turnaraound time) 5 ml blood EDTA/Saliva SRD5A1-S Steroid 5-alpha-reductase *184753 cds SRD5A1 1 month Oncologic on swab 5 ml blood EDTA/Saliva ABL1-S ABL1, Gene *189980 cds ABL1 3 months Oncologic on swab 5 ml blood EDTA/Saliva GCDH-S Glutaric Acidemia Type I 231670 cds GCDH 4 weeks Metabolic on swab ACAT1, BCKDHA, BCKDHB, DBT, 251000, 251100, 251110, GCDH, HMGCL, IVD, MMAA, ACID-N Isolated Methylmalonic Acidemia 251120, 277410, 607481, cds 5 ml blood EDTA 3 months Metabolic MMAB, MMACHC, MCCC1, 607568, 608419, 609058 MCCC2, MUT, PCCA, PCCB 5 ml blood EDTA/Saliva SLC4A1-S Renal Tubular Distal Acidosis 611590 cds SLC4A1 6 weeks Hematologic on swab 5 ml blood EDTA/Saliva AUH-S 3-methylglutaconic aciduria, type I 250950 cds AUH 2 months Metabolic on swab 5 ml blood EDTA/Saliva IDH2-S D-2-hydroxyglutaric aciduria 2 613657 cds IDH2 6 weeks Multisystemic on swab ACYL-COA Dehydrogenase Medium-Chain, c.985A>G 5 ml blood EDTA/Saliva ACADM-V 201450 ACADM 1 month Metabolic Deficiency of (p.Lys304Glu) on swab ACYL-COA Dehydrogenase Medium-Chain, ACADM-S 201450 cds ACADM 5 ml blood EDTA 2 months Metabolic Deficiency of 5 ml blood EDTA/Saliva FGFR3-V Achondroplasia 100800 p.G380R, p.G375C FGFR3 2 weeks Musculoskeletal on swab 5 ml blood EDTA/Saliva ITGB2-S Leukocyte adhesion deficiency (LAD) 116920 cds ITGB2 2 months Hematologic on swab 5 ml blood EDTA/Saliva ADIPOQ-V Adiponectin (Hipoadiponectinemia) 612556 c.276G>T ADIPOQ 1 week Metabolic on swab ABCD1-D Adrenoleukodystrophy
    [Show full text]
  • PMC5805680.Pdf
    ARTICLE DOI: 10.1038/s41467-018-02942-5 OPEN Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer Alison P. Klein et al.# In 2020, 146,063 deaths due to pancreatic cancer are estimated to occur in Europe and the United States combined. To identify common susceptibility alleles, we performed the largest pancreatic cancer GWAS to date, including 9040 patients and 12,496 controls of European 1234567890():,; ancestry from the Pancreatic Cancer Cohort Consortium (PanScan) and the Pancreatic Cancer Case-Control Consortium (PanC4). Here, we find significant evidence of a novel association at rs78417682 (7p12/TNS3, P = 4.35 × 10−8). Replication of 10 promising signals in up to 2737 patients and 4752 controls from the PANcreatic Disease ReseArch (PAN- DoRA) consortium yields new genome-wide significant loci: rs13303010 at 1p36.33 (NOC2L, P = 8.36 × 10−14), rs2941471 at 8q21.11 (HNF4G, P = 6.60 × 10−10), rs4795218 at 17q12 (HNF1B, P = 1.32 × 10−8), and rs1517037 at 18q21.32 (GRP, P = 3.28 × 10−8). rs78417682 is not statistically significantly associated with pancreatic cancer in PANDoRA. Expression quan- titative trait locus analysis in three independent pancreatic data sets provides molecular support of NOC2L as a pancreatic cancer susceptibility gene. Correspondence and requests for materials should be addressed to A.P.K. (email: [email protected]) or to L.T.A. (email: [email protected]) #A full list of authors and their affliations appears at the end of the paper. NATURE COMMUNICATIONS | (2018) 9:556 | DOI:
    [Show full text]
  • Abstracts of Lectures Gfh ÖGH SGMG Tagungsband Abstracts
    patients were significantly different across pop mosomal level, but not generally at both levels. Abstracts of Lectures ulations with frequency maximum of the com In this view, the aneuploid karyotype is the read mon mutations in EastEurope (W151X, V326L), out of an underlying chromosomal instability NorthWestEurope (IVS81G>C), and SouthEu (CIN). In a small proportion of cancers display 1. Symposia rope (T93M). ing CIN the loss of this checkpoint is associated Carrier frequency analysis of the IVS81G>C, with the mutational inactivation of a human ho W151X, T93M, and V326L mutations in 2250 mologue of the yeast BUB1 gene. BUB1 controls S1 healthy individuals from different European pop mitotic checkpoints and chromosome segrega ulations revealed much higher frequencies for tion in yeast. The Human SHOX Mutation Database these common mutations (e.g. 1:50 for the IVS8 Because the MIN and CIN forms of instability are Beate Niesler, Christine Fischer and Gudrun A. 1G>C in Austria, and 1:84 for the W151X in rarely found to coexist in tumours, it would seem Rappold Poland) than expected from the reported preva that one form of instability is sufficient to drive Institute of Human Genetics, University of lence of the SLOS. Based on these frequencies tumorigenesis. Heidelberg, Im Neuenheimer Feld 328, the expected incidence of SLOS patients with Genetic instability appears early in tumorigene 69120 Heidelberg, Germany null mutations ranges from 1:2000 to 1:16.000. sis and is believed to play a critical role in the The human SHOX gene (Short Stature Home This discrepancy might be due to underdiagno malignant process.
    [Show full text]